These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 18237469)

  • 1. Anti-tumour effects of HL-37, a novel anthracene derivative, in-vivo and in-vitro.
    Xie SQ; Hu GQ; Zhang ZQ; Xu M; Ji BS
    J Pharm Pharmacol; 2008 Feb; 60(2):213-9. PubMed ID: 18237469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of stealthy liposomal topotecan plus amlodipine on the multidrug-resistant leukaemia cells in vitro and xenograft in mice.
    Li X; Lu WL; Liang GW; Ruan GR; Hong HY; Long C; Zhang YT; Liu Y; Wang JC; Zhang X; Zhang Q
    Eur J Clin Invest; 2006 Jun; 36(6):409-18. PubMed ID: 16684125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HL-37, a novel anthracene derivative, induces Ca(2+)-mediated apoptosis in human breast cancer cells.
    Xie SQ; Zhang ZQ; Hu GQ; Xu M; Ji BS
    Toxicology; 2008 Dec; 254(1-2):68-74. PubMed ID: 18948164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antimultidrug-resistant effect and mechanism of a novel CA-4 analogue MZ3 on leukemia cells.
    Xu D; Fang L; Zhu Q; Hu Y; He Q; Yang B
    Pharmazie; 2008 Jul; 63(7):528-33. PubMed ID: 18717489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The activity of Selol in multidrug-resistant and sensitive human leukemia cells.
    Suchocki P; Misiewicz I; Skupinska K; Waclawek K; Fijalek Z; Kasprzycka-Guttman T
    Oncol Rep; 2007 Oct; 18(4):893-9. PubMed ID: 17786352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quinoline derivative KB3-1 potentiates paclitaxel induced cytotoxicity and cycle arrest via multidrug resistance reversal in MES-SA/DX5 cancer cells.
    Koo JS; Choi WC; Rhee YH; Lee HJ; Lee EO; Ahn KS; Bae HS; Ahn KS; Kang JM; Choi SU; Kim MO; Lu J; Kim SH
    Life Sci; 2008 Nov; 83(21-22):700-8. PubMed ID: 18845169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new apoptosis inhibitor, CIAPIN1 (cytokine-induced apoptosis inhibitor 1), mediates multidrug resistance in leukemia cells by regulating MDR-1, Bcl-2, and Bax.
    Li X; Hong L; Zhao Y; Jin H; Fan R; Du R; Xia L; Luo G; Fan D
    Biochem Cell Biol; 2007 Dec; 85(6):741-50. PubMed ID: 18059532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Imatinib resistance in multidrug-resistant K562 human leukemic cells.
    Assef Y; Rubio F; Coló G; del Mónaco S; Costas MA; Kotsias BA
    Leuk Res; 2009 May; 33(5):710-6. PubMed ID: 18977528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lgf-YL-9 induces apoptosis in human epidermoid carcinoma KB cells and multidrug resistant KBv200 cells via reactive oxygen species-independent mitochondrial pathway.
    Wang XH; Jia DZ; Liang YJ; Yan SL; Ding Y; Chen LM; Shi Z; Zeng MS; Liu GF; Fu LW
    Cancer Lett; 2007 May; 249(2):256-70. PubMed ID: 17055640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. H1, a derivative of Tetrandrine, exerts anti-MDR activity by initiating intrinsic apoptosis pathway and inhibiting the activation of Erk1/2 and Akt1/2.
    Wei N; Liu GT; Chen XG; Liu Q; Wang FP; Sun H
    Biochem Pharmacol; 2011 Dec; 82(11):1593-603. PubMed ID: 21864508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced therapeutic effects on the multi-drug resistant human leukemia cells in vitro and xenograft in mice using the stealthy liposomal vincristine plus quinacrine.
    Liang GW; Lu WL; Wu JW; Zhao JH; Hong HY; Long C; Li T; Zhang YT; Zhang H; Wang JC; Zhang X; Zhang Q
    Fundam Clin Pharmacol; 2008 Aug; 22(4):429-37. PubMed ID: 18705753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Substituted tetrahydroisoquinoline compound B3 inhibited P-glycoprotein-mediated multidrug resistance in-vitro and in-vivo.
    Fang W; Li Y; Cai Y; Kang K; Yan F; Liu G; Huang W
    J Pharm Pharmacol; 2007 Dec; 59(12):1649-55. PubMed ID: 18053326
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CJY, an isoflavone, reverses P-glycoprotein-mediated multidrug-resistance in doxorubicin-resistant human myelogenous leukaemia (K562/DOX) cells.
    Ji BS; He L
    J Pharm Pharmacol; 2007 Jul; 59(7):1011-5. PubMed ID: 17637197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N,N-dimethyl phytosphingosine induces caspase-8-dependent cytochrome c release and apoptosis through ROS generation in human leukemia cells.
    Kim BM; Choi YJ; Han Y; Yun YS; Hong SH
    Toxicol Appl Pharmacol; 2009 Aug; 239(1):87-97. PubMed ID: 19481559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of a daunorubicin analogue that exhibits potent antitumor activity and overcomes P-gp-mediated drug resistance.
    Fang L; Zhang G; Li C; Zheng X; Zhu L; Xiao JJ; Szakacs G; Nadas J; Chan KK; Wang PG; Sun D
    J Med Chem; 2006 Feb; 49(3):932-41. PubMed ID: 16451059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antimony-trioxide- and arsenic-trioxide-induced apoptosis in myelogenic and lymphatic cell lines, recruitment of caspases, and loss of mitochondrial membrane potential are enhanced by modulators of the cellular glutathione redox system.
    Lösler S; Schlief S; Kneifel C; Thiel E; Schrezenmeier H; Rojewski MT
    Ann Hematol; 2009 Nov; 88(11):1047-58. PubMed ID: 19301004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutational analysis of P-glycoprotein: suppression of caspase activation in the absence of ATP-dependent drug efflux.
    Tainton KM; Smyth MJ; Jackson JT; Tanner JE; Cerruti L; Jane SM; Darcy PK; Johnstone RW
    Cell Death Differ; 2004 Sep; 11(9):1028-37. PubMed ID: 15131592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficient induction of apoptosis by doxorubicin coupled to cell-penetrating peptides compared to unconjugated doxorubicin in the human breast cancer cell line MDA-MB 231.
    Aroui S; Brahim S; De Waard M; Bréard J; Kenani A
    Cancer Lett; 2009 Nov; 285(1):28-38. PubMed ID: 19523755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HZ08, a great regulator to reverse multidrug resistance via cycle arrest and apoptosis sensitization in MCF-7/ADM.
    Cen J; Qi Y; Tao YF; Deng Y; Fang WR; Li YM; Zhang LY; Huang WL
    Eur J Pharmacol; 2010 Nov; 647(1-3):21-30. PubMed ID: 20816813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lentivirus-mediated RNA interference reversing the drug-resistance in MDR1 single-factor resistant cell line K562/MDR1.
    Ye X; Liu T; Gong Y; Zheng B; Meng W; Leng Y
    Leuk Res; 2009 Aug; 33(8):1114-9. PubMed ID: 19036441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.